Focal Radiotherapy for Previously Treated Prostate Cancer Patients

Recruiting N/A Interventional Study
Locally Recurrent Prostate Cancer
No Placebo Group Every participant receives an active treatment — no one gets a placebo.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
18 and older
Sex
Male
Study type
Interventional
Purpose
Treatment
Participants needed
36 (estimated)
Sponsor
Royal North Shore Hospital · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial

To examine the feasibility, safety and toxicity of focal stereotactic radiation treatment (SBRT) for locally recurrent prostate cancer.

Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: * Men \> 4yrs from external beam radiotherapy (EBRT) meeting the Phoenix definition of biochemical failure or men \> 5yrs from EBRT if neo-adjuvant and/or adjuvant androgen deprivation therapy (ADT) also used * Recurrence localised to less than 1 lobe of prostate on both PMSA an…
Contacts

Carolyn Kwong

+61 2 9463 1339

carolyn.kwong@health.nsw.gov.au

CONTACT

Heidi Tsang

+61 2 9463 1340

heidi.tsang@health.nsw.gov.au

CONTACT